Cleara
Utrecht, NL · Founded 2018 · 10 employees on LinkedIn · 3 known investors
Find your way into Cleara
180 people in our graph share verified history with the Cleara team — schools, employers, funds. One of them is your warm intro.
René Kuijtenunlockedknows Peter de Keizer · together at Utrecht University (overlapped)
×5knows the team · via Harvard Medical School
×4knows the team · via Utrecht University
×2knows the team · via UMC Utrecht
Cleara Biotech develops compounds to eliminate senescent cells for treating late-stage cancer and chronic age-related diseases. The company translates academic research on cellular senescence into clinical therapeutics.
Founders & leadership
Cleara was founded in 2018 by Peter de Keizer and Tobias Madl.
PD
Peter de KeizerinFounder and Managing DirectorPeter de Keizer is an associate professor at UMC Utrecht and founder of Cleara Biotech, which develops therapeutics targeting senescent cells for cancer and age-related diseases. His research focuses on understanding cellular senescence mechanisms and developing cell-penetrating peptides and imaging approaches to identify and eliminate specific senescent cell subtypes.
TM
Tobias MadlHead of Structural Biology, Scientific Co-founder
Investors · 3
Founder mafia
2 people who came through Cleara went on to found or lead other companies.
In the news
Frequently asked questions
- What does Cleara do?
- Cleara Biotech develops compounds to eliminate senescent cells for treating late-stage cancer and chronic age-related diseases. The company translates academic research on cellular senescence into clinical therapeutics.
- Who founded Cleara?
- Cleara was founded by Peter de Keizer, Tobias Madl in 2018.
- Who are Cleara's investors?
- Cleara's investors include CoastCap, Curie Capital, Korify Capital.
- Where is Cleara headquartered?
- Cleara is headquartered in Utrecht, NL.